Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Vaxcyte, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 223
- +21 vs. Q3 2023
- Shares held
- 103.1M
- +1.71M (+1.7%) vs. Q3 2023
- Total value
- $6.47B
- +$1.31B (+25.3%) vs. Q3 2023
- New holders
- 37
- 87 more added
- Sold out
- 16
- 68 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 1,076,920 | $67.6M | 0.03% | +120,985+12.7% | Added |
| Perceptive Advisors LLC | 1,088,486 | $68.4M | 1.53% | −254,265−18.9% | Reduced |
| Commodore Capital LP | 1,100,000 | $69.1M | 6.04% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 1,149,209 | $72.2M | 0.08% | −325,573−22.1% | Reduced |
| OrbiMed Advisors LLC | 1,153,091 | $72.4M | 1.45% | +145,943+14.5% | Added |
| Frazier Life Sciences Management, L.P. | 1,164,405 | $73.1M | 3.91% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 1,246,041 | $78.3M | 0.05% | +41,413+3.4% | Added |
| Braidwell LP | 1,289,965 | $81.0M | 2.98% | −329,588−20.4% | Reduced |
| Westfield Capital Management Co LP | 1,455,593 | $91.4M | 0.53% | +451,677+45.0% | Added |
| Jennison Associates LLC | 1,476,154 | $92.7M | 0.07% | −278,537−15.9% | Reduced |
| Fred Alger Management, LLC | 1,670,189 | $104.9M | 0.57% | −423,116−20.2% | Reduced |
| Driehaus Capital Management LLC | 1,674,368 | $105.2M | 1.27% | +350,484+26.5% | Added |
| Alliancebernstein L.P. | 1,915,047 | $120.3M | 0.05% | −28,783−1.5% | Reduced |
| Geode Capital Management, LLC | 1,973,506 | $123.9M | 0.01% | +98,392+5.2% | Added |
| Price T Rowe Associates Inc | 2,677,822 | $168.2M | 0.02% | +260,170+10.8% | Added |
| State Street Corp | 3,389,528 | $212.9M | 0.01% | +244,269+7.8% | Added |
| Capital Research Global Investors | 3,440,107 | $216.0M | 0.05% | +75,980+2.3% | Added |
| Wellington Management Group LLP | 4,431,920 | $278.3M | 0.05% | −166,792−3.6% | Reduced |
| Janus Henderson Group PLC | 6,981,376 | $438.4M | 0.26% | −79,212−1.1% | Reduced |
| Ra Capital Management, L.P. | 7,891,254 | $495.6M | 7.74% | 00.0% | Unchanged |
| Vanguard Group Inc | 8,452,371 | $530.8M | 0.01% | +168,125+2.0% | Added |
| BlackRock Inc. | 8,575,847 | $538.6M | 0.01% | +1,154,596+15.6% | Added |
| FMR LLC | 14,213,365 | $892.6M | 0.07% | +136,328+1.0% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% | −1,049,893−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −142,417−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −67,500−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −58,472−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −43,329−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −34,970−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −27,980−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −27,919−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,106−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −17,289−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −7,082−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −4,696−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| TSFG, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −6−100.0% | Sold out |